260 related articles for article (PubMed ID: 9708554)
1. In vivo differentiation of astrocytic brain tumors and isolated demyelinating lesions of the type seen in multiple sclerosis using 1H magnetic resonance spectroscopic imaging.
De Stefano N; Caramanos Z; Preul MC; Francis G; Antel JP; Arnold DL
Ann Neurol; 1998 Aug; 44(2):273-8. PubMed ID: 9708554
[TBL] [Abstract][Full Text] [Related]
2. Spectroscopic magnetic resonance imaging of a tumefactive demyelinating lesion.
Law M; Meltzer DE; Cha S
Neuroradiology; 2002 Dec; 44(12):986-9. PubMed ID: 12483443
[TBL] [Abstract][Full Text] [Related]
3. The use of proton MRS in the differential diagnosis of brain tumors and tumor-like processes.
Gajewicz W; Papierz W; Szymczak W; Goraj B
Med Sci Monit; 2003 Sep; 9(9):MT97-105. PubMed ID: 12960934
[TBL] [Abstract][Full Text] [Related]
4. Proton magnetic resonance spectroscopic imaging to differentiate between nonneoplastic lesions and brain tumors in children.
Hourani R; Horská A; Albayram S; Brant LJ; Melhem E; Cohen KJ; Burger PC; Weingart JD; Carson B; Wharam MD; Barker PB
J Magn Reson Imaging; 2006 Feb; 23(2):99-107. PubMed ID: 16374884
[TBL] [Abstract][Full Text] [Related]
5. [Application of 1H-magnetic resonance spectroscopy in differential diagnosis of brain low-grade gliomas and demyelinating diseases].
Hou XY; Gao PY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Apr; 31(2):206-9. PubMed ID: 19507601
[TBL] [Abstract][Full Text] [Related]
6. Metabolic differences between primary and recurrent human brain tumors: a 1H NMR spectroscopic investigation.
Lehnhardt FG; Bock C; Röhn G; Ernestus RI; Hoehn M
NMR Biomed; 2005 Oct; 18(6):371-82. PubMed ID: 15959923
[TBL] [Abstract][Full Text] [Related]
7. [MR tomography of astrocytic tumors (I-III)].
Pedrosa P; Grigat M; Higer HP; Straube U; Schaeben W; Gutjahr P; Voth D; Kunze S
Rofo; 1989 Jan; 150(1):52-7. PubMed ID: 2536497
[TBL] [Abstract][Full Text] [Related]
8. Adult primitive neuroectodermal tumor: proton MR spectroscopic findings with possible application for differential diagnosis.
Majós C; Alonso J; Aguilera C; Serrallonga M; Acebes JJ; Arús C; Gili J
Radiology; 2002 Nov; 225(2):556-66. PubMed ID: 12409595
[TBL] [Abstract][Full Text] [Related]
9. In vitro study of astrocytic tumour metabolism by proton magnetic resonance spectroscopy.
Likavcanová K; Dobrota D; Liptaj T; Prónayová N; Mlynárik V; Belan V; Galanda M; Béres A; De Riggo J
Gen Physiol Biophys; 2005 Sep; 24(3):327-35. PubMed ID: 16308427
[TBL] [Abstract][Full Text] [Related]
10. Combined use of F-18 fluorocholine positron emission tomography and magnetic resonance spectroscopy for brain tumor evaluation.
Kwee SA; Coel MN; Lim J; Ko JP
J Neuroimaging; 2004 Jul; 14(3):285-9. PubMed ID: 15228773
[TBL] [Abstract][Full Text] [Related]
11. Characterization of tumefactive demyelinating lesions using MR imaging and in-vivo proton MR spectroscopy.
Malhotra HS; Jain KK; Agarwal A; Singh MK; Yadav SK; Husain M; Krishnani N; Gupta RK
Mult Scler; 2009 Feb; 15(2):193-203. PubMed ID: 19181773
[TBL] [Abstract][Full Text] [Related]
12. Proton magnetic resonance spectroscopy of brain tumors correlated with pathology.
Magalhaes A; Godfrey W; Shen Y; Hu J; Smith W
Acad Radiol; 2005 Jan; 12(1):51-7. PubMed ID: 15691725
[TBL] [Abstract][Full Text] [Related]
13. Astrocytoma-like multiple sclerosis.
Pakos EE; Tsekeris PG; Chatzidimou K; Goussia AC; Markoula S; Argyropoulou MI; Pitouli EG; Konitsiotis S
Clin Neurol Neurosurg; 2005 Feb; 107(2):152-7. PubMed ID: 15708234
[TBL] [Abstract][Full Text] [Related]
14. Characteristic neuroimaging in patients with tumefactive demyelinating lesions exceeding 30 mm.
Kiriyama T; Kataoka H; Taoka T; Tonomura Y; Terashima M; Morikawa M; Tanizawa E; Kawahara M; Furiya Y; Sugie K; Kichikawa K; Ueno S
J Neuroimaging; 2011 Apr; 21(2):e69-77. PubMed ID: 20572907
[TBL] [Abstract][Full Text] [Related]
15. Monofocal acute inflammatory Demyelination (MAID): a unique disorder simulating brain neoplasm.
Gutrecht JA; Berger JR; Jones RH; Mancall AC
South Med J; 2002 Oct; 95(10):1180-6. PubMed ID: 12425506
[TBL] [Abstract][Full Text] [Related]
16. MRI of high-grade astrocytic tumors: early appearance and evolution.
Okamoto K; Ito J; Takahashi N; Ishikawa K; Furusawa T; Tokiguchi S; Sakai K
Neuroradiology; 2002 May; 44(5):395-402. PubMed ID: 12012123
[TBL] [Abstract][Full Text] [Related]
17. [Application of (1)H MR spectroscopic imaging in radiation oncology: choline as a marker for determining the relative probability of tumor progression after radiation of glial brain tumors].
Lichy MP; Bachert P; Hamprecht F; Weber MA; Debus J; Schulz-Ertner D; Schlemmer HP; Kauczor HU
Rofo; 2006 Jun; 178(6):627-33. PubMed ID: 16703499
[TBL] [Abstract][Full Text] [Related]
18. Differentiation of glioblastoma multiforme from astrocytomas by in vitro 1H MRS analysis of human brain tumors.
Carpinelli G; Carapella CM; Palombi L; Raus L; Caroli F; Podo F
Anticancer Res; 1996; 16(3B):1559-63. PubMed ID: 8694526
[TBL] [Abstract][Full Text] [Related]
19. [Diffusion-weighted MRI in the differentiation of brain abscesses and necrotic tumors].
Hakyemez B; Ergin N; Uysal S; Işik I; Kiliç E
Tani Girisim Radyol; 2004 Jun; 10(2):110-8. PubMed ID: 15236124
[TBL] [Abstract][Full Text] [Related]
20. 3D MRSI for resected high-grade gliomas before RT: tumor extent according to metabolic activity in relation to MRI.
Pirzkall A; Li X; Oh J; Chang S; Berger MS; Larson DA; Verhey LJ; Dillon WP; Nelson SJ
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):126-37. PubMed ID: 15093908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
